OCOcugen OCGN · NASDAQ
$0.82 -6.63% (-$0.06)
- Market cap
- $276.9M
- Enterprise value
- $339.1M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 57.9x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -94.4%
- Gross margin
- 59.2%
- Net margin
- -1,367.6%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.27
- Free float
- 98.6%
About the company
Ocugen (OCGN) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products. Its primary goal is to provide patients with high therapeutic value medicines and contribute to improving their health outcomes. The company specializes in the treatment of ocular diseases, including rare eye disorders. Ocugen stock is suitable for investors interested in the biotechnology sector and those who want to support innovative treatment approaches. Add Ocugen stock to your watchlist on Bulios and gain access to the latest information about this company that is pushing the boundaries of ocular disease management.
Sector
Healthcare
Industry
Biotechnology
CEO
Shankar Musunuri
Employees
116
Headquarters
Malvern
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 21% a year over the last 3 years.
- What speaks for it: Analysts expect revenue to grow by 12% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number